Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis

Attila Csaba Nagy, Ágnes Tóth, Natália Bak, Battamir Ulambayar, Amr Sayed Ghanem, Ferenc Sztanek · 2024

Read Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis by Attila Csaba Nagy, Ágnes Tóth, Natália Bak, Battamir Ulambayar, Amr Sayed Ghanem, Ferenc Sztanek (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642396.txt.

Description

Diabetes drugs that flush sugar out in urine have surprised doctors by protecting the heart. Attila Nagy and co-authors checked in 2024 whether that protection shows up as fewer new heart failure cases in everyday practice.

They followed 2,542 people with type 2 diabetes in a clinical database from 2016 to 2020, excluding insulin users. Patients on the drugs had about half the odds of a heart failure event, after accounting for age, sex, and blood sugar control. Kidney function and sex also shaped the risk. The authors present the drugs as preventive therapy worth considering for high-risk diabetic patients, beyond their sugar-lowering job.

Catalog record

CREATORAttila Csaba Nagy, Ágnes Tóth, Natália Bak, Battamir Ulambayar, Amr Sayed Ghanem, Ferenc Sztanek
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11642396

Browse the full library · About the Tower of Babel